Get 20% lifetime commission for referring investors to digrin.com
here.
NRx Pharmaceuticals, Inc. ( NRXP) - Key Metrics
NRXP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.03 | -$0.44 | -$0.24 | -$0.26 |
| 2026Q1 | $0.03 | -$0.04 | -$0.13 | -$0.13 |
| 2025Q4 | $0.03 | $0.01 | -$0.12 | -$0.12 |
| 2025Q3 | $0.01 | -$0.26 | -$0.13 | -$0.13 |
| 2025Q2 | $0 | -$0.98 | -$0.22 | -$0.22 |
NRXP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.32 |
| 2026Q1 | 0% | -12.05 |
| 2025Q4 | 0% | 59.96 |
| 2025Q3 | 0% | -3.06 |
| 2025Q2 | 0% | -0.83 |
NRXP
Price: $2.60
52 week price:
Earnings Per Share: -0.51 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 246900
Market Capitalization: 125.8 million